123 related articles for article (PubMed ID: 38823016)
1. NR4A1 transcriptionally regulates the differentiation of stem-like CD8
Hao J; Li R; Zhao X; Liu X; Chen X; Xie T; Li X; Yao C; Sun Q; Wei K; Gou M; Chi X; Xu W; Ni L; Dong C
Cell Rep; 2024 May; 43(6):114301. PubMed ID: 38823016
[TBL] [Abstract][Full Text] [Related]
2. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
Lee J; Lee K; Bae H; Lee K; Lee S; Ma J; Jo K; Kim I; Jee B; Kang M; Im SJ
Front Immunol; 2023; 14():1117092. PubMed ID: 37409128
[TBL] [Abstract][Full Text] [Related]
3. Precursor exhausted CD8
Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
[TBL] [Abstract][Full Text] [Related]
4. NR4a1/2 deletion promotes accumulation of TCF1
Srirat T; Hayakawa T; Mise-Omata S; Nakagawara K; Ando M; Shichino S; Ito M; Yoshimura A
Cell Rep; 2024 Mar; 43(3):113898. PubMed ID: 38451819
[TBL] [Abstract][Full Text] [Related]
5. Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T cells in distinct cellular niches.
Dähling S; Mansilla AM; Knöpper K; Grafen A; Utzschneider DT; Ugur M; Whitney PG; Bachem A; Arampatzi P; Imdahl F; Kaisho T; Zehn D; Klauschen F; Garbi N; Kallies A; Saliba AE; Gasteiger G; Bedoui S; Kastenmüller W
Immunity; 2022 Apr; 55(4):656-670.e8. PubMed ID: 35366396
[TBL] [Abstract][Full Text] [Related]
6. HMGB2 regulates the differentiation and stemness of exhausted CD8
Neubert EN; DeRogatis JM; Lewis SA; Viramontes KM; Ortega P; Henriquez ML; Buisson R; Messaoudi I; Tinoco R
Nat Commun; 2023 Sep; 14(1):5631. PubMed ID: 37704621
[TBL] [Abstract][Full Text] [Related]
7. Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells.
Fang Z; Ding X; Huang H; Jiang H; Jiang J; Zheng X
Cancer Biol Med; 2024 May; ():. PubMed ID: 38825813
[TBL] [Abstract][Full Text] [Related]
8. MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
Tsui C; Kretschmer L; Rapelius S; Gabriel SS; Chisanga D; Knöpper K; Utzschneider DT; Nüssing S; Liao Y; Mason T; Torres SV; Wilcox SA; Kanev K; Jarosch S; Leube J; Nutt SL; Zehn D; Parish IA; Kastenmüller W; Shi W; Buchholz VR; Kallies A
Nature; 2022 Sep; 609(7926):354-360. PubMed ID: 35978192
[TBL] [Abstract][Full Text] [Related]
9. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
Front Immunol; 2022; 13():869768. PubMed ID: 35774790
[TBL] [Abstract][Full Text] [Related]
10. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.
Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
[TBL] [Abstract][Full Text] [Related]
12. Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1
Humblin E; Korpas I; Lu J; Filipescu D; van der Heide V; Goldstein S; Vaidya A; Soares-Schanoski A; Casati B; Selvan ME; Gümüş ZH; Wieland A; Corrado M; Cohen-Gould L; Bernstein E; Homann D; Chipuk J; Kamphorst AO
Sci Immunol; 2023 Aug; 8(86):eadg0878. PubMed ID: 37624910
[TBL] [Abstract][Full Text] [Related]
13. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion.
Mohankumar K; Wright G; Kumaravel S; Shrestha R; Zhang L; Abdelrahim M; Chapkin RS; Safe S
Cancer Immunol Immunother; 2023 Dec; 72(12):3985-3999. PubMed ID: 37847301
[TBL] [Abstract][Full Text] [Related]
14. Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8
Chen CY; Ueha S; Ishiwata Y; Shichino S; Yokochi S; Yang D; Oppenheim JJ; Ogiwara H; Deshimaru S; Kanno Y; Aoki H; Ogawa T; Shibayama S; Matsushima K
Cancer Immunol Res; 2021 Oct; 9(10):1214-1228. PubMed ID: 34344641
[TBL] [Abstract][Full Text] [Related]
15. Gfi1 controls the formation of effector CD8 T cells during chronic infection and cancer.
Ojo OA; Shen H; Ingram JT; Bonner JA; Welner RS; Lacaud G; Zajac AJ; Shi LZ
bioRxiv; 2024 Apr; ():. PubMed ID: 38659890
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.
Liu X; Wang Y; Lu H; Li J; Yan X; Xiao M; Hao J; Alekseev A; Khong H; Chen T; Huang R; Wu J; Zhao Q; Wu Q; Xu S; Wang X; Jin W; Yu S; Wang Y; Wei L; Wang A; Zhong B; Ni L; Liu X; Nurieva R; Ye L; Tian Q; Bian XW; Dong C
Nature; 2019 Mar; 567(7749):525-529. PubMed ID: 30814730
[TBL] [Abstract][Full Text] [Related]
17. Stem-like progenitor and terminally differentiated T
Zhou W; Kawashima S; Ishino T; Kawase K; Ueda Y; Yamashita K; Watanabe T; Kawazu M; Dansako H; Suzuki Y; Nishikawa H; Inozume T; Nagasaki J; Togashi Y
Cell Rep; 2024 Feb; 43(2):113797. PubMed ID: 38363680
[TBL] [Abstract][Full Text] [Related]
18. Progenitor-like exhausted SPRY1
Liu Z; Zhang Y; Ma N; Yang Y; Ma Y; Wang F; Wang Y; Wei J; Chen H; Tartarone A; Velotta JB; Dayyani F; Gabriel E; Wakefield CJ; Kidane B; Carbonelli C; Long L; Liu Z; Su J; Li Z
Cancer Cell; 2023 Nov; 41(11):1852-1870.e9. PubMed ID: 37832554
[TBL] [Abstract][Full Text] [Related]
19. Dynamic CD8
Rahim MK; Okholm TLH; Jones KB; McCarthy EE; Liu CC; Yee JL; Tamaki SJ; Marquez DM; Tenvooren I; Wai K; Cheung A; Davidson BR; Johri V; Samad B; O'Gorman WE; Krummel MF; van Zante A; Combes AJ; Angelo M; Fong L; Algazi AP; Ha P; Spitzer MH
Cell; 2023 Mar; 186(6):1127-1143.e18. PubMed ID: 36931243
[TBL] [Abstract][Full Text] [Related]
20. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
Front Immunol; 2020; 11():622509. PubMed ID: 33633741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
